Cost of medication nonadherence associated with diabetes, hypertension, and dyslipidemia

American Journal of Pharmacy Benefits

Volumn 4, Issue 2, 2012, Pages

  Nasseh, Kamyar ^a   Frazee, Sharon Glave ^a   Visaria, Jay ^a   Vlahiotis, Anna ^a   Tian, Yuhong ^a  

^a Express Scripts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; COST BENEFIT ANALYSIS; COST CONTROL; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH INSURANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICATION NONADHERENCE; PATIENT COMPLIANCE; PHARMACY BENEFIT MANAGER; POPULATION RESEARCH; PREVALENCE; SENSITIVITY ANALYSIS;

EID: 84859741495     PISSN: 19454481     EISSN: 21642494     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979.
2. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes: a critical review. Arch Intern Med. 1997;157(17): 1921-1929.
3. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794-811.
4. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and health care cost. Med Care. 2005;43(6): 521-530.
5. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Affairs (Millwood). 2011;30(1):91-99.
6. Stuart BC, Simoni-Wastila L, Zhao L, Lloyd JT, Doshi JA. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 2009;32(4):647-649.
7. Noncompliance with Medications: An Economic Tragedy with Important Implications for Health Care Reform. Washington, DC:The Task Force for Compliance; 1994:1-32.
8. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353: 487-497.
9. Bureau of Labor Statistics. Consumer Price Index Medical Component. All Urban Consumers. http://www.bls.gov/data. Accessed January 27, 2011.
10. New England Healthcare Institute (NEHI). Thinking outside the pillbox: A system-wide approach to improving patient medication adherence for chronic disease. http://www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_to_improving_patient_medication_adherence_for_chronic_disease. Accessed January 19, 2011.
11. 2009 and 2010 demographic and population characteristics. United States Census. http://www.census.gov/popest/estimates.html. Accessed January 27, 2011.
12. Centers for Disease Control, Office of Surveillance, Epidemiology, and Laboratory Services; Behavioral Risk Factor Surveillance System. Disease Prevalence and Trends Data: Nationwide (States and DC) 2009. http://apps.nccd.cdc.gov/brfss/page.asp?yr=2009&state=UB&cat=DE#DE. Accessed January 19, 2011.
13. Centers for Disease Control, Office of Surveillance, Epidemiology, and Laboratory Services. Overview: BRFSS 2009. http://www.cdc.gov/brfss/technical_infodata/surveydata/2009/overview_09.rtf. Accessed July 27, 2011.
14. Peterson AM, Nau DP, Cramer JA, Benner J, Gwardry-Srdihar F, Nichol F. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10(1):3-12.
15. Andrade S, Kahler K, Frech F, Chan K. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiology & Drug Safety. 2006;15(8):565-574.
16. Kaiser Family Foundation. Health Insurance Coverage of Adults (2008-2009). http://www.statehealthfacts.org/profileind.jsp?ind=130&cat=3&rgn=1. Accessed January 27, 2011.
17. Duru OK, Vargas RB, Kermah D, Pan D, Norris KC. Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens. 2007; 20(4):348-353.
18. Mochari H, Ferris A, Adigopula S, Henry G, Mosca L. Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population. Prev Cardiol. 2007;10(4):190-195.
19. Kennedy J, Morgan S. A cross-national study of nonadherence due to cost: data from the Joint Canada-United States Survey of Health. Clin Ther. 2006;28(8): 1217-1224.
20. Levine D, Morgenstern LB, Langa KM, Piette JD. Cost-related nonadherence to medication among U.S. stroke survivors after Medicare Part D implementation: American Stroke Association International Stroke Conference. ASA. 2011;Abstract 212.
21. Fryar CD, Hirsch R, Eberhardt MS, Yoon SS, Wright JD. Hypertension, high serum cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. Adults: 1999-2006. CDC NCHS Data Brief. 2010;36:1-8.
22. Centers for Disease Control. 2005-2008 National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes.htm. Accessed July 25, 2011.
23. Boslaugh S, ed. Encyclopedia of Epidemiology. Vol 1. Los Angeles, CA: Sage Publications; 2008.
24. Ahluwalia IB, Mack KA, Murphy W, Mokdad AH, Bales VS. State specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001. MMWR Surveill Summ. 2003;52:1-80.
25. Stuart B, Davidoff A, Lopert R, Shafer T, Shoemaker JS, Lloyd J. Does medication adherence lower Medicare spending among beneficiaries with diabetes? Health Serv Res. 2011;46(4):1180-1199.
26. Esposito D, Bagchi AD, Verdier JM, Bencio DS, Kim MS. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. Am J Manag Care. 2009;15(7):437-445.
27. HealthCare.gov. Understanding the affordable care act. http://www.healthcare.gov/law/introduction/index.html. Accessed March 11, 2011.